Literature DB >> 9490075

Immunochemical studies of the lipopolysaccharide O-specific polysaccharide of Hafnia alvei PCM 1199 related to H. alvei PCM 1205.

E Katzenellenbogen1, N A Kocharova, G V Zatonsky, M Mieszala, A Gamian, M Bogulska, A S Shashkov, E Romanowska, Y A Knirel.   

Abstract

On the basis of chemical analyses and NMR spectroscopic studies, it was found that the O-specific polysaccharide (O-PS) isolated from the Hafnia alvei PCM 1199 lipopolysaccharide (LPS) is a glycerol teichoic-acid-like polymer having a repeating unit of the following structure: [structure in text] where Qui4NAc is 4-acetamido-4,6-dideoxyglucose and O-acetylation at both positions is non-stoichiometric. The glycosidic linkage of the lateral beta-D-GlcpNAc residue is acid-labile and cleaved from the O-PS during mild acid hydrolysis or dephosphorylation with 48% hydrofluoric acid. Comparative analysis revealed that the structure of the H. alvei PCM 1199 O-PS is similar to that of H. alvei PCM 1205, which differs in the presence of an additional lateral alpha-D-Glcp residue and the position of one of the O-acetyl groups only. Accordingly, serological tests revealed a high degree of serological similarity between LPSs and O-PSs of the two H. alvei strains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9490075     DOI: 10.1046/j.1432-1327.1998.2510980.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  2 in total

1.  Nonradiolabeling assay for WaaP, an essential sugar kinase involved in biosynthesis of core lipopolysaccharide of Pseudomonas aeruginosa.

Authors:  Xin Zhao; Cory Q Wenzel; Joseph S Lam
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  Immunochemical studies of the lipopolysaccharides of Hafnia alvei PCM 1219 and other strains with the O-antigens containing D-glucose 1-phosphate and 2-deoxy-2-[(R)-3-hydroxybutyramido]-D-glucose.

Authors:  Ewa Katzenellenbogen; Nina A Kocharova; Agnieszka Korzeniowska-Kowal; Andrzej Gamian; Maria Bogulska; Bernadeta Szostko; Alexander S Shashkov; Yuriy A Knirel
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008 Sep-Oct       Impact factor: 4.291

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.